Investor Overview

Investors hero image

Corporate Profile


Rocket Pharmaceuticals, Inc. is a fully integrated, late-stage biotechnology company focused on advancing a sustainable pipeline of investigational genetic therapies designed to correct the root cause of complex and rare disorders.  Rocket’s innovative multi-platform approach allows us to design the optimal gene therapy for each indication, creating potentially transformative options that enable people living with devastating rare diseases to experience long and full lives.

Stock Information

(Common Stock)

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Scroll to Top